{"id":"W2016065032","doi":"10.1097/mph.0b013e31815815f6","title":"Prolonged Response to Oral Gefitinib, Cyclophophamide, and Topotecan in Heavily Pretreated Relapsed Stage 4 Neuroblastoma","year":2007,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Gefitinib; Topotecan; Neuroblastoma; Stage (stratigraphy); Oncology; Internal medicine; Chemotherapy; Cancer; Epidermal growth factor receptor; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933984,0.0003335798,0.001092417,0.0002013644,0.0004079641,0.0001677036,0.0003161936,0.000539841,0.0005684713],"category_scores_gemma":[0.0005140371,0.0001723538,0.0003305754,0.0002566656,0.0002575164,0.0001733665,0.0001987621,0.0007645233,0.0001618739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008156135,"about_ca_system_score_gemma":0.0003632213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002478772,"about_ca_topic_score_gemma":0.008153915,"domain_scores_codex":[0.9998815,0.00002663624,0.00001482609,0.00001892496,0.00002037519,0.00003772759],"domain_scores_gemma":[0.9997819,0.00006534979,0.00004026376,0.00001251018,0.00001087225,0.00008916666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.03818093,0.003219352,0.1626824,0.0009532601,0.0005268907,0.3709604,0.001690336,0.005849124,0.2054799,0.0004590516,0.004656824,0.2053415],"study_design_scores_gemma":[0.004633068,0.05843352,0.4951755,0.0001441042,0.0008236805,0.358779,0.0008974506,0.004683039,0.05575459,0.0006635959,0.01989812,0.000114316],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997285,0.001584958,0.0001302424,0.0002400745,0.0000187029,0.00002329703,0.00007316471,0.00001589013,0.0006287062],"genre_scores_gemma":[0.9978404,0.001059322,0.0003089866,0.0001065892,0.00003266908,0.0000236521,0.0002082456,0.00000825709,0.0004118537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002478772,"threshold_uncertainty_score":0.005917728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02215726575831171,"score_gpt":0.3549229994326704,"score_spread":0.3327657336743587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}